Identification of essential genes associated with SARS-CoV-2 infection as potential drug target candidates with machine learning algorithms

被引:0
|
作者
Golnaz Taheri
Mahnaz Habibi
机构
[1] Stockholm University,Department of Computer and Systems Sciences
[2] Science for Life Laboratory,Department of Mathematics, Qazvin Branch
[3] Islamic Azad University,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) requires the fast discovery of effective treatments to fight this worldwide concern. Several genes associated with the SARS-CoV-2, which are essential for its functionality, pathogenesis, and survival, have been identified. These genes, which play crucial roles in SARS-CoV-2 infection, are considered potential therapeutic targets. Developing drugs against these essential genes to inhibit their regular functions could be a good approach for COVID-19 treatment. Artificial intelligence and machine learning methods provide powerful infrastructures for interpreting and understanding the available data and can assist in finding fast explanations and cures. We propose a method to highlight the essential genes that play crucial roles in SARS-CoV-2 pathogenesis. For this purpose, we define eleven informative topological and biological features for the biological and PPI networks constructed on gene sets that correspond to COVID-19. Then, we use three different unsupervised learning algorithms with different approaches to rank the important genes with respect to our defined informative features. Finally, we present a set of 18 important genes related to COVID-19. Materials and implementations are available at: https://github.com/MahnazHabibi/Gene_analysis.
引用
收藏
相关论文
共 50 条
  • [1] Identification of essential genes associated with SARS-CoV-2 infection as potential drug target candidates with machine learning algorithms
    Taheri, Golnaz
    Habibi, Mahnaz
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [2] Machine learning algorithms for identification of SARS-CoV-2 in neonates
    Dobrijevic, D.
    Katanic, J.
    Pastor, K.
    CLINICA CHIMICA ACTA, 2024, 558
  • [3] Classification of SARS-CoV-2 and non-SARS-CoV-2 using machine learning algorithms
    Singh, Om Prakash
    Vallejo, Marta
    El-Badawy, Ismail M.
    Aysha, Ali
    Madhanagopal, Jagannathan
    Faudzi, Ahmad Athif Mohd
    COMPUTERS IN BIOLOGY AND MEDICINE, 2021, 136
  • [4] Molecular targets in SARS-CoV-2 infection: An update on repurposed drug candidates
    Rahmani, Dibachehr
    Jafari, Ameneh
    Kesharwani, Prashant
    Sahebkar, Amirhossein
    PATHOLOGY RESEARCH AND PRACTICE, 2024, 263
  • [5] Indole-Based Compounds as Potential Drug Candidates for SARS-CoV-2
    Girgis, Adel S.
    Panda, Siva S.
    Kariuki, Benson M.
    Bekheit, Mohamed S.
    Barghash, Reham F.
    Aboshouk, Dalia R.
    Previti, Santo
    Ettari, Roberta
    MOLECULES, 2023, 28 (18):
  • [6] Mapping Drug-gene Interactions to Identify Potential Drug Candidates Targeting Envelope Protein in SARS-CoV-2 Infection
    Ghosh, Byapti
    Das, Troyee
    Das, Gourab
    Chowdhury, Nilkanta
    Bagchi, Angshuman
    Ghosh, Zhumur
    CURRENT BIOINFORMATICS, 2023, 18 (09) : 760 - 773
  • [7] Target and drug predictions for SARS-CoV-2 infection in hepatocellular carcinoma patients
    Wang, Luhong
    Ding, Yinan
    Zhang, Chuanyong
    Chen, Rong
    PLOS ONE, 2022, 17 (05):
  • [8] Target and drug predictions for SARS-CoV-2 infection in hepatocellular carcinoma patients
    Wang, Luhong
    Ding, Yinan
    Zhang, Chuanyong
    Chen, Rong
    PLOS ONE, 2023, 17 (05):
  • [9] Identification of methylation signatures and rules for predicting the severity of SARS-CoV-2 infection with machine learning methods
    Liu, Zhiyang
    Meng, Mei
    Ding, ShiJian
    Zhou, XiaoChao
    Feng, KaiYan
    Huang, Tao
    Cai, Yu-Dong
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [10] Drug Re-purposing from SARS-CoV Led the Identification of Potential Candidate Drug Target and Alternate Drug Molecules Against SARS-CoV-2
    Arun, P. V. Parvati Sai
    Hussain, Razak
    Akhter, Yusuf
    Rao, Mandava Venkata Basaveswara
    Shyam, Perugu
    Yellaboina, Sailu
    LETTERS IN DRUG DESIGN & DISCOVERY, 2020, 17 (10) : 1325 - 1327